SCHEMBL5741501

SCHEMBL5741501

CNc1ccc(Cl)cc1Sc1ccccc1Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.44
▸ HPGD P15428 3/20 0.44
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ MAPT P10636 1/20 0.41
▸ ITGB2 P05107 6/20 0.40
▸ ICAM1 P05362 6/20 0.40
▸ ITGAL P20701 6/20 0.40
▸ PRMT1 Q99873 1/20 0.40
▸ RHEB Q15382 3/20 0.40
▸ PDE7A Q13946 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ GLA P06280 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ HTT P42858 2/20 0.39
▸ CYP3A4 P08684 2/20 0.39
▸ CYP2D6 P10635 2/20 0.39
▸ CYP2C9 P11712 2/20 0.39
▸ PLA2G1B P04054 1/20 0.39
▸ HSP90AA1 P07900 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31222333 0.81 PDE7A (0.46) ALDH1A1HPGDMEN1KMT2AMAPT
SCHEMBL28846956 0.74 ALDH1A1 (0.46) ALDH1A1HPGDMEN1KMT2AMAPT
SCHEMBL29543966 0.73 RHEB (0.55) ALDH1A1HPGDKMT2AMAPTPRMT1
SCHEMBL6915666 0.73 RHEB (0.55) ALDH1A1HPGDKMT2AMAPTPRMT1
SCHEMBL6244315 0.71 L3MBTL1 (0.46) ALDH1A1HPGDMEN1KMT2AMAPT
SCHEMBL30548744 0.71 RHEB (0.53) ALDH1A1HPGDKMT2AMAPTPRMT1
SCHEMBL10767306 0.70 SLC6A2 (0.59) ALDH1A1HPGDMEN1KMT2AMAPT
SCHEMBL29829144 0.70 PDE7A (0.53) ALDH1A1HPGDMEN1KMT2AMAPT
SCHEMBL27999929 0.70 SLC6A2 (0.54) ALDH1A1HPGDMEN1KMT2AMAPT
SCHEMBL989608 0.69 ALDH1A1 (0.52) ALDH1A1HPGDKDM4EGLAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1157006-B1 PHENYL- AND PYRIDINYL DERIVATIVES AS NEUROKININ 1 ANTAGONISTS HOFFMANN LA ROCHE (CH) 2006-10-25 — — EP disclosed
CN-1131212-C Phenyl-and pyridinyl derivatives HOFFMANN LA ROCHE (CH) 2003-12-17 — — CN disclosed
US-6596773-B2 Central nervous system disorders HOFFMANN-LA ROCHE INC. 2003-07-22 — — US disclosed
US-20020111367-A1 Phenyl substituted pyridine and benzene derivatives BOS MICHAEL (CA) 2002-08-15 — — US disclosed
US-6407111-B1 SUBSTANCE P OR NEUROKININ 1 ANTAGONISTS; ANTIINFLAMMATORY, ANTIDEPRESSANT, ANTIARTHRITIC, AND ANTIASTHMATIC AGENTS; PARKINSON*S DISEASE, INFLAMMATORY BOWEL DISEASE, CENTRAL NERVOUS SYSTEM AND RHEUMATIC DISORDERS HOFFMANN-LA ROCHE INC. 2002-06-18 — — US disclosed
CN-1341101-A Phenyl-and pyridinyl derivatives HOFFMANN LA ROCHE (CH) 2002-03-20 — — CN disclosed
EP-1157006-A2 PHENYL- AND PYRIDINYL DERIVATIVES AS NEUROKININ 1 ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2001-11-28 — — EP disclosed
WO-2000050398-A2 PHENYL- AND PYRIDINYL DERIVATIVES AS NEUROKININ 1 ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2000-08-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020111367-A1 Phenyl substituted pyridine and benzene derivatives BDKRB1, BAK1, PBK ALDH1A1 754/4885HPGD 1634/4885MEN1 4317/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback